95 results
Page 4 of 5
F-1/A
EX-1.1
1siuvoumuv57k5l4 0e
9 Oct 20
Registration statement (foreign) (amended)
12:00am
F-1/A
n1mq2l0oeudv70jmqpj
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
o8r6rp wk2mk
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
segordx1zuon2
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
zbj0kmt93zk4 20uwv98
3 Aug 20
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.3
nygyuvlo37
1 Jul 20
Report of Foreign Private Issuer
9:05am
6-K
EX-99.2
c3bjehwlngyaw
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
i4f5a9xgls9nybdv
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
EX-4.7
3krs3g4pg8bymslyqxj
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
awz0wu
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
xj4bcfd0
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
EX-4.7
jn63rc0evps6z
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
7767rbwlo25cn7 s5
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.7
yfszefi1deg
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1/A
v807gqm0fpka8yh2
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
pdb6d8mf yn2sgn9
31 Jan 20
Registration statement (foreign)
12:00am
424B5
afagtk lxn6xx4
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
xz82q9y607 qr1
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
yrgclvoxv50qq 4e
3 Dec 19
Current report (foreign)
12:00am